1. Home
  2. NTRA vs DVN Comparison

NTRA vs DVN Comparison

Compare NTRA & DVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$400.92

Market Cap

47.4B

Sector

Health Care

ML Signal

N/A

Logo Devon Energy Corporation

DVN

Devon Energy Corporation

N/A

Current Price

$48.20

Market Cap

53.1B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
DVN
Founded
2003
1971
Country
United States
United States
Employees
N/A
2200
Industry
Medical Specialities
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
47.4B
53.1B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
NTRA
DVN
Price
$400.92
$48.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
23
28
Target Price
★ $383.66
$60.96
AVG Volume (30 Days)
1.7M
★ 9.7M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 2.62%
EPS Growth
★ 0.65
N/A
EPS
N/A
★ 2.60
Revenue
$210,939,000.00
★ $17,188,000,000.00
Revenue This Year
$26.17
$58.62
Revenue Next Year
$20.65
$3.90
P/E Ratio
★ N/A
$18.82
Revenue Growth
N/A
★ 7.83
52 Week Low
$169.50
$31.47
52 Week High
$437.41
$52.71

Technical Indicators

Market Signals
Indicator
NTRA
DVN
Relative Strength Index (RSI) 61.52 53.29
Support Level $187.64 $45.86
Resistance Level N/A $49.93
Average True Range (ATR) 17.33 1.26
MACD -3.35 0.04
Stochastic Oscillator 50.04 68.55

Price Performance

Historical Comparison
NTRA
DVN

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DVN Devon Energy Corporation

Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two-thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko and Bakken basins. After the merger with Coterra, it will have a foothold in the gas-driven Appalachian Basin as well. At the end of 2025, Devon reported net proved reserves of 2.4 billion barrels of oil equivalent, up from 2.2 billion in 2024. Net production averaged roughly 840,000 barrels of oil equivalent per day in 2025 at a ratio of 73% oil and natural gas liquids and 27% natural gas.

Share on Social Networks: